# Cluster4-12 Analysis

## Proteins: 

ALMS1, ARMCX5, BORCS7, CRY2, CSTPP1, GNAQ, GNB5, IFT57, INTS5, LIMK1, LMTK2, MAGEA4, MAPK14, PLEKHN1, PPP1R16B, PRKAA1, SMC4, TAB1, TAB3, TSC22D3

### Cytosolic Protein Interaction System

**Summary**

The human protein system analyzed here consists of 20 proteins, with the majority involved in protein binding (19 proteins) and located in the cytosol (12 proteins). The proteins are also involved in various cellular components such as the nucleus, cytoplasm, nuclear speck, plasma membrane, and mitochondrion. Key biological processes performed by this system include signal transduction, protein phosphorylation, and regulation of transcription. Based on the cellular location and function, we propose the name "Cytosolic Protein Interaction System" for this protein system.

The Cytosolic Protein Interaction System appears to be involved in a wide range of cellular processes, including stress fiber assembly, glucose homeostasis, circadian rhythm, and apoptotic processes. Some proteins, such as CRY2, PRKAA1, and MAPK14, are involved in multiple processes, suggesting that they may play a central role in this system. Additionally, several proteins are involved in kinase activity and protein phosphorylation, which are crucial for signal transduction and regulation of cellular processes.

It is unclear if this is a novel complex or if any proteins are novel members of a known complex. Further investigation and experimental validation are needed to determine the novelty and functional significance of this protein system.

**References**

1. [Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource.](https://academic.oup.com/nar/article/32/suppl_1/D258/2505269) Nucleic Acids Res. 2004 Jan 1;32(Database issue):D258-61. doi: 10.1093/nar/gkh036.

2. [UniProt: a worldwide hub of protein knowledge.](https://academic.oup.com/nar/article/47/D1/D506/5146203) Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515. doi: 10.1093/nar/gky1049.

3. [STRING: functional protein association networks.](https://academic.oup.com/nar/article/45/W1/W362/3787862) Nucleic Acids Res. 2017 Jul 3;45(W1):W362-W368. doi: 10.1093/nar/gkx535.

### Validated References: 

None





## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 19 | ARMCX5, BORCS7, CRY2, CSTPP1, GNAQ, GNB5, IFT57, INTS5, LIMK1, LMTK2, MAGEA4, MAPK14, PLEKHN1, PPP1R16B, PRKAA1, SMC4, TAB1, TAB3, TSC22D3 |
| cytosol | 12 | ALMS1, CRY2, GNB5, INTS5, LIMK1, LMTK2, MAPK14, PRKAA1, SMC4, TAB1, TAB3, TSC22D3 |
| nucleus | 10 | CRY2, GNB5, INTS5, LIMK1, MAGEA4, MAPK14, PPP1R16B, PRKAA1, SMC4, TSC22D3 |
| cytoplasm | 9 | CRY2, CSTPP1, GNAQ, GNB5, INTS5, LIMK1, MAPK14, PPP1R16B, PRKAA1 |
| nuclear speck | 7 | CRY2, LIMK1, MAPK14, PPP1R16B, PRKAA1, SMC4, TAB1 |
| ATP binding | 5 | LIMK1, LMTK2, MAPK14, PRKAA1, SMC4 |
| plasma membrane | 4 | GNAQ, PLEKHN1, PPP1R16B, TAB3 |
| signal transduction | 4 | GNB5, LIMK1, MAPK14, PRKAA1 |
| nucleoplasm | 4 | INTS5, MAPK14, PRKAA1, SMC4 |
| protein serine/threonine kinase activity | 4 | LIMK1, LMTK2, MAPK14, PRKAA1 |
| protein serine kinase activity | 4 | LIMK1, LMTK2, MAPK14, PRKAA1 |
| mitochondrion | 3 | CRY2, MAPK14, PLEKHN1 |
| metal ion binding | 3 | GNAQ, LIMK1, PRKAA1 |
| Golgi apparatus | 3 | GNAQ, IFT57, LMTK2 |
| membrane | 3 | INTS5, LIMK1, LMTK2 |
| protein kinase activity | 3 | LIMK1, LMTK2, PRKAA1 |
| protein phosphorylation | 3 | LIMK1, LMTK2, PRKAA1 |
| molecular_function | 2 | ALMS1, MAGEA4 |
|  stress fiber assembly | 2 | ALMS1, LIMK1 |
| spindle pole | 2 | ALMS1, MAPK14 |
| centrosome | 2 | ALMS1, IFT57 |
| cilium | 2 | ALMS1, IFT57 |
| DNA binding | 2 | CRY2, IFT57 |
| single-stranded DNA binding | 2 | CRY2, SMC4 |
| negative regulation of transcription by RNA polymerase II | 2 | CRY2, MAGEA4 |
| response to activity | 2 | CRY2, PRKAA1 |
| response to insulin | 2 | CRY2, MAPK14 |
| glucose homeostasis | 2 | CRY2, PRKAA1 |
|  circadian rhythm | 2 | CRY2, PRKAA1 |
| extracellular region | 2 | CRY2, MAPK14 |
| enzyme activator activity | 2 | CSTPP1, TAB1 |
| GTPase activity | 2 | GNAQ, GNB5 |
| GTPase activator activity | 2 | GNAQ, GNB5 |
| heterotrimeric G-protein complex | 2 | GNAQ, GNB5 |
| nuclear membrane | 2 | GNAQ, INTS5 |
| extracellular exosome | 2 | GNAQ, TAB3 |
| apoptotic process | 2 | IFT57, MAPK14 |
|  apoptotic process | 2 | IFT57, PLEKHN1 |
| cytoskeleton | 2 | LIMK1, PLEKHN1 |
| peptidyl-serine phosphorylation | 2 | LMTK2, MAPK14 |
| neuronal cell body | 2 | LMTK2, PRKAA1 |
| perinuclear region of cytoplasm | 2 | LMTK2, PPP1R16B |
| negative regulation of apoptotic process | 2 | MAGEA4, PRKAA1 |
| mitogen-activated protein kinase p38 binding | 2 | MAPK14, TAB1 |
| glucose metabolic process | 2 | MAPK14, PRKAA1 |
|  transcription by RNA polymerase II | 2 | MAPK14, TSC22D3 |
|  gene expression | 2 | MAPK14, PRKAA1 |
| fatty acid oxidation | 2 | MAPK14, PRKAA1 |
| intracellular signal transduction | 2 | MAPK14, PRKAA1 |
| response to hypoxia | 2 | PLEKHN1, PRKAA1 |
| chromatin binding | 2 | PRKAA1, SMC4 |
| protein-containing complex binding | 2 | PRKAA1, TAB1 |
| endosome membrane | 2 | TAB1, TAB3 |

